$273.88 -6.32 (%) Actavis PLC - NYSE

Jan. 28, 2015 | 04:00 PM

Partner Headlines

  1. White House Budget To Support Biotech Rally

    Benzinga | Jan. 27, 2015 | 16:00PM EST
  2. Citigroup Ponders How Results From Namenda Survey Might Affect Actavis

    Benzinga | Jan. 27, 2015 | 09:48AM EST
  3. Benzinga's M&A Chatter for Monday January 26, 2015

    Benzinga | Jan. 26, 2015 | 17:46PM EST
  4. Actavis Surges Amid Acquisition Of Auden Mckenzie For £306 Million

    Benzinga | Jan. 26, 2015 | 11:45AM EST
  5. Wave Of Monday Mergers Spans Drugs To Corn Flakes

    Benzinga | Jan. 26, 2015 | 10:55AM EST
  6. UPDATE: Actavis Reports Purchase of Auden Mckenzie for £306M

    Benzinga | Jan. 26, 2015 | 07:34AM EST
  7. Pharmaceuticals Sector To See High Voltage Action in 2015

    GuruFocus | Jan. 23, 2015 | 16:13PM EST
  8. Top World Stocks Close In On Buy Points, New Highs

    IBD | Jan. 22, 2015 | 18:36PM EST
  9. Stocks Grab Third Straight Gain; Baidu Nears Resistance

    IBD | Jan. 21, 2015 | 16:19PM EST
  10. Stocks Hold Near Day's Highs; Actavis Retakes Buy Point

    IBD | Jan. 21, 2015 | 13:19PM EST
  11. Salix Pharma Reportedly Exploring Sale; Stock Up

    IBD | Jan. 20, 2015 | 15:06PM EST
  12. 3 Reasons To Be Bullish On Generic Drug Firm Akorn

    IBD | Jan. 15, 2015 | 14:12PM EST
  13. After Hours Movers

    Benzinga | Jan. 14, 2015 | 17:15PM EST
  14. Meet 5 Top Medical Stocks Making Waves This Week

    IBD | Jan. 14, 2015 | 08:02AM EST
  15. 10 World Stocks, Including 3 New Highs And 3 Bases

    IBD | Jan. 13, 2015 | 18:16PM EST
  16. Celgene, Bristol-Myers Cancer Drug News Lifts Stocks

    IBD | Jan. 12, 2015 | 18:48PM EST
  17. Stocks Close Sharply Lower; Medicals Move On Announcements

    IBD | Jan. 12, 2015 | 16:23PM EST
  18. Celgene Says Q4 Earnings Beat, Sees Currency Impact

    IBD | Jan. 12, 2015 | 13:12PM EST
  19. Four Best Gains In IBD 50: Nothing To Do With Oil

    IBD | Jan. 9, 2015 | 18:11PM EST
  20. Four Hot Growth Stocks To Put On Your Watch List

    IBD | Jan. 8, 2015 | 18:06PM EST
  21. Will Allergan Buy Help Actavis Extend Growth Streak?

    IBD | Jan. 6, 2015 | 18:17PM EST
  22. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga | Jan. 6, 2015 | 06:56AM EST
  23. IBD 50 Tone Darkens; More Leaders Below 10-Week Line

    IBD | Jan. 2, 2015 | 18:13PM EST
  24. An Investor's Guide: Market-Leading Industries In 2014

    IBD | Jan. 2, 2015 | 14:57PM EST
  25. Stocks Reverse Lower; Apple Plunges Below Support

    IBD | Jan. 2, 2015 | 11:59AM EST
  26. These 5 Big Caps Saw Sales Surge Last Quarter

    IBD | Dec. 31, 2014 | 08:02AM EST
  27. U.S. M&A Seen Staying Robust In 2015, Fueled By Oil

    IBD | Dec. 29, 2014 | 18:38PM EST
  28. Actavis, Valeant Largely Avoid Gilead's Hepatitis Dive

    IBD | Dec. 22, 2014 | 18:23PM EST
  29. Energy Sector Seen as Biggest Risk to Deal Flow in 2015

    FoxBusiness | Dec. 22, 2014 | 09:00AM EST
  30. Actavis 8-K Shows $1B Revolving Credit Facility Replacing Existing $750M Pact; Term Loan Credit Pact In 2 Tranches Of $2.75B Each

    Benzinga | Dec. 22, 2014 | 06:43AM EST
  31. Baidu, Alibaba Among Top World Stocks Building Bases

    IBD | Dec. 18, 2014 | 18:09PM EST
  32. Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside

    Benzinga | Dec. 18, 2014 | 16:15PM EST
  33. Tetraphase Jumps As 'Superbug' Drug Scores In Trial

    IBD | Dec. 18, 2014 | 11:54AM EST
  34. Great Stocks: Valeant Pharmaceuticals Near Buy Point

    IBD | Dec. 16, 2014 | 18:11PM EST
  35. Actavis Announces Proposed Senior Leadership Team Effective Following Completion of Allergan Acquisition

    Benzinga | Dec. 16, 2014 | 07:32AM EST
  36. The Gurus to Follow Based on Sector - Part 2

    GuruFocus | Dec. 9, 2014 | 16:20PM EST
  37. Stock Market Today: Wall Street Drops; Conn's Down 40%

    IBD | Dec. 9, 2014 | 11:55AM EST
  38. Valeant Abandoning its Growth by Acquisition Strategy -Reuters

    Benzinga | Dec. 9, 2014 | 05:13AM EST
  39. Top Global Stocks: Jazz, Actavis In IBD's World List

    IBD | Dec. 8, 2014 | 18:31PM EST
  40. Merck Acquiring Cubist, Focusing On Hospital Care

    IBD | Dec. 8, 2014 | 11:48AM EST
  41. Bank Of America: How To Profit From An Aging Population

    Benzinga | Dec. 5, 2014 | 10:46AM EST
  42. Great Stocks In 2014: Airline, Video Game, Drugs Lead

    IBD | Dec. 4, 2014 | 18:53PM EST
  43. Great Stocks: Mallinckrodt Buys Raise Profit Margins

    IBD | Dec. 4, 2014 | 18:20PM EST
  44. Dodge & Cox's Top New Buys of Q3

    GuruFocus | Dec. 4, 2014 | 12:26PM EST
  45. Top Funds Gobble Up Tech And Medical Stocks

    IBD | Dec. 2, 2014 | 18:19PM EST
  46. U.S. Stock Mutual Funds Led Advance In November

    IBD | Dec. 2, 2014 | 18:19PM EST
  47. Larry Robbins Lives Up to Reputation for Investing in Healthcare Sector

    GuruFocus | Dec. 1, 2014 | 16:59PM EST
  48. UPDATE: Actavis Launches Generic Version of Intuniv

    Benzinga | Dec. 1, 2014 | 16:06PM EST
  49. Valeant Rises After Allergan Snub; Zeltiq In Buy Area

    IBD | Nov. 19, 2014 | 18:14PM EST
  50. Mallinckrodt Q4 Earnings Beat Views, But Outlook Hazy

    IBD | Nov. 19, 2014 | 17:35PM EST
Trading Center